| 000 | 01718 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518070124.0 | ||
| 264 | 0 | _c20210104 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-19-2631 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCasey, Dana L | |
| 245 | 0 | 0 |
_aGenomic Determinants of Clinical Outcomes in Rhabdomyosarcoma. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c03 2020 |
||
| 300 |
_a1135-1140 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHigh-Throughput Nucleotide Sequencing _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWexler, Leonard H | |
| 700 | 1 | _aPitter, Kenneth L | |
| 700 | 1 | _aSamstein, Robert M | |
| 700 | 1 | _aSlotkin, Emily K | |
| 700 | 1 | _aWolden, Suzanne L | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 26 _gno. 5 _gp. 1135-1140 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-19-2631 _zAvailable from publisher's website |
| 999 |
_c30286189 _d30286189 |
||